Original Articles
Vol. 2 No. 1 (2023)
Attitude to clinical research among health professionals affiliated with the Italian Federation of Centers for the Diagnosis of Thrombotic Disorders and the Surveillance of the Antithrombotic Therapies (FCSA)
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Received: 9 November 2022
Accepted: 14 February 2023
Accepted: 14 February 2023
634
Views
245
Downloads
Authors
Clinical research is vital in supporting evidence-based practice. However, several barriers make participation in research difficult. We performed a survey to evaluate the attitude to research of the members of the Italian Anticoagulation Clinics. The survey includes 19 closed questions on the perception of participating in research and exploring the benefit that health professionals wish to obtain. A total of 167 questionnaires were returned from 97/220 (44.1%) Centers, of which 89.7% were not academic. Participants (median age 56 years, range 29-75y; 56.3% females) were equally distributed all over the country; 151/167 (90.4%) of respondents believe that participating in research helps to reduce the routine of their work and allows a better quality of work, 72/167 (43.1%) complain heavy workload. More than 74% of respondents would like to participate in scientific meetings, without difference in relation to age. Instead, inclusion in the authorship of a scientific paper is of relevance for 75.6% of respondents ≤50 years and for 65.2% of respondents >50 years. A substantial positive attitude towards research was evident, suggesting that independent scientific societies could be of valuable support for the growth of research culture.
Downloads
Download data is not yet available.
Citations
Johnson C, Lizama C, Harrison M, et al. Cancer health professionals need funding, time, research knowledge and skills to be involved in health services research. J Cancer Educ. 2014;29:389-94. DOI: https://doi.org/10.1007/s13187-014-0625-y
Mant D, Del Mar C, Glasziou P, et al. The state of primary-care research. Lancet. 2004;364:1004-6. DOI: https://doi.org/10.1016/S0140-6736(04)17027-X
Kalucy EC, Jackson-Bowers E, McIntyre E, et al. The feasibility of determining the impact of primary health care research projects using the Payback Framework. Health Res Policy Syst. 2009;7:11. DOI: https://doi.org/10.1186/1478-4505-7-11
Rahman S, Majumder MA, Shaban SF, et al. Physician participation in clinical research and trials: issues and approaches. Adv Med Educ Pract. 2011;2:85-93. DOI: https://doi.org/10.2147/AMEP.S14103
Harding K, Lynch L, Porter J, et al. Organisational benefits of a strong research culture in a health service: a systematic review. Aust Health Rev. 2017;41:45-53. DOI: https://doi.org/10.1071/AH15180
Skinner EH, Williams CM, Haines TP. Embedding research culture and productivity in hospital physiotherapy departments: challenges and opportunities. Aust Health Rev. 2015;39:312-4. DOI: https://doi.org/10.1071/AH14212
Palareti G, Leali N, Coccheri S, et al. Bleeding complications of oral anticoagulant treatment: an inception- cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy. Lancet. 1996;348:423-8. DOI: https://doi.org/10.1016/S0140-6736(96)01109-9
Palareti G, Legnani C, Guazzaloca G, et al. Risks factors for highly unstable response to oral anticoagulation: a case-control study. Br J Haematol. 2005;129:72-8. DOI: https://doi.org/10.1111/j.1365-2141.2005.05417.x
Pengo V, Cucchini U, Denas G, et al. Standardized low-molecular-weight heparin bridging regimen in outpatients on oral anticoagulants undergoing invasive procedure or surgery: an inception cohort management study. Circulation. 2009;119:2920-7. DOI: https://doi.org/10.1161/CIRCULATIONAHA.108.823211
Poli D, Antonucci E, Testa S, et al. Bleeding risk in very old patients on vitamin K antagonist treatment: results of a prospective collaborative study on elderly patients followed by Italian Centres for Anticoagulation. Circulation. 2011;124:824-9. DOI: https://doi.org/10.1161/CIRCULATIONAHA.110.007864
Poli D, Antonucci E, Dentali F, et al. Recurrence of ICH after resumption of anticoagulation with VK antagonists: CHIRONE study. Neurology. 2014;82:1020-6. DOI: https://doi.org/10.1212/WNL.0000000000000245
Tosetto A, Manotti C, Marongiu F, et al. Center-Related Determinants of VKA Anticoagulation Quality: A Prospective, Multicenter Evaluation. PLoS One. 2015;10:e0144314. DOI: https://doi.org/10.1371/journal.pone.0144314
Poli D, Antonucci E, Pengo V, et al. Mechanical prosthetic heart valves: Quality of anticoagulation and thromboembolic risk. The observational multicenter PLECTRUM study. Int J Cardiol. 2018;267:68-73. DOI: https://doi.org/10.1016/j.ijcard.2018.04.042
Antonucci E, Poli D, Tosetto A, et al. The Italian START-Register on Anticoagulation with Focus on Atrial Fibrillation. PLoS One. 2015;10:e0124719. DOI: https://doi.org/10.1371/journal.pone.0124719
Chokshi NK, Simeone DM, Chari RS, et al. A survey of academic surgeons: work, stress, and research. Surgery. 2009;146:462-8. DOI: https://doi.org/10.1016/j.surg.2009.02.015
Paget SP, Lilischkis KJ, Morrow AM, et al. Embedding research in clinical practice: differences in attitudes to research participation among clinicians in a tertiary teaching hospital. Intern Med J. 2014;44:86-9. DOI: https://doi.org/10.1111/imj.12330
Caldwell B, Coltart K, Hutchison C, et al. Research awareness, attitudes and barriers among clinical staff in a regional cancer centre. Part 1: a quantitative analysis. Eur J Cancer Care (Engl). 2017;26. DOI: https://doi.org/10.1111/ecc.12434
Sistema di valutazione della performance dei sistemi sanitari regionali [Available from: https://www.santannapisa.it/it/terza-missione/sistema-di-valutazione-della-performance-dei-sistemi-sanitari-regionali.
Russo PS, T.; Romano, F. . Il valore della spesa sanitaria in Italia dal 1990 al 2016. GIHTAD. 2019;12:1-6.
How to Cite
1.
Poli D, Tartaglia R, Barcellona D, Bucciarelli P, Ciampa A, Grandone E, et al. Attitude to clinical research among health professionals affiliated with the Italian Federation of Centers for the Diagnosis of Thrombotic Disorders and the Surveillance of the Antithrombotic Therapies (FCSA). Bleeding Thromb Vascul Biol [Internet]. 2023 Mar. 21 [cited 2025 Oct. 7];2(1). Available from: https://www.btvb.org/btvb/article/view/59
Copyright (c) 2023 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Similar Articles
- Mattia Galli, C. Michael Gibson, Dominick J. Angiolillo, Factor XI inhibitors in adjunct to antiplatelet therapy: the ultimate dual-pathway inhibition? , Bleeding, Thrombosis and Vascular Biology: Vol. 2 No. 3 (2023)
- Coenraad H. Hemker, The clinical usefulness of measuring thrombin generation , Bleeding, Thrombosis and Vascular Biology: Vol. 2 No. 1 (2023)
- Betül Ünlü, Neha Joshi, Jamie M. O'Sullivan, Endothelial cell dysfunction in cancer: a not-so-innocent bystander , Bleeding, Thrombosis and Vascular Biology: Vol. 3 No. s1 (2024)
- Ronda Lun, Deborah M. Siegal, Cancer-associated ischemic stroke: current knowledge and future directions , Bleeding, Thrombosis and Vascular Biology: Vol. 3 No. s1 (2024)
- Marcello Di Nisio, Matteo Candeloro, Nicola Potere, Ettore Porreca, Jeffrey I. Weitz, Factor XI inhibitors: a new option for the prevention and treatment of cancer-associated thrombosis , Bleeding, Thrombosis and Vascular Biology: Vol. 3 No. s1 (2024)
- Kristen M. Sanfilippo, Tzu-Fei Wang, Venous thromboembolism and mortality in patients with hematological malignancies , Bleeding, Thrombosis and Vascular Biology: Vol. 3 No. s1 (2024)
- Gary E. Raskob, Risk of recurrent venous thromboembolism in cancer patients after discontinuation of anticoagulant therapy , Bleeding, Thrombosis and Vascular Biology: Vol. 3 No. s1 (2024)
- Sergio Coccheri, A re-appraisal of thrombogenesis in COVID-19, seen as a multiple "Complex system" , Bleeding, Thrombosis and Vascular Biology: Vol. 1 No. 3 (2022)
- Daniela Tormene, Elena Campello, Chiara Simion, Anna Poretto, Paolo Prandoni, Paolo Simioni, Combined oral contraceptives and the risk of venous thromboembolism carriers of antithrombin, protein C or S deficiency: Sub-analysis of a prospective cohort study , Bleeding, Thrombosis and Vascular Biology: Vol. 1 No. 3 (2022)
- Paolo Prandoni, Personalized bleeding risk assessment for atrial fibrillation patients on direct oral anticoagulants: the DOAC score , Bleeding, Thrombosis and Vascular Biology: Vol. 2 No. 3 (2023)
You may also start an advanced similarity search for this article.
